At the end of 2023, South West London Pathology (SWLP) awarded a managed service contract for histopathology to Leica Biosystems. The new contract will secure standardised automation and technology that will help to future-proof histopathology services at SWLP for the foreseeable future.
Leica is a global leader in anatomic pathology solutions with a mission of advancing cancer diagnostics. It is operational in 35 countries and has six manufacturing sites.
SWLP Managing Director Simon Brewer says, “I am excited to be working with Leica biosystems to develop our histopathology services. Leica aligns with our values and vison of innovation, automation and digital pathology.
“At a time of unequalled pressures on histopathology laboratories across the country, Leica will bring us the most up-to-date and innovative technology on the market and will allow us to use automation to improve and standardise our services.”